Business
FDA Orphan Drug Designation for PBT2 for Huntington Disease
FDA Orphan Drug Designation for PBT2 for Huntington Disease
About this update from Alterity Therapeutics Ltd.
[{"type":"text","content":"Alterity Therapeutics Ltd has released a press release. View Attachment","length":254,"tagName":"div"}]